Imaging cellular metabolic heterogeneity in cancer

Melissa C. Skala, Alex J. Walsh, Amy T. Shah, Joseph T. Sharick, Tiffany M. Heaster, Rebecca S. Cook, Carlos L. Arteaga, Melinda E. Sanders, Ingrid Meszoely

Research output: Chapter in Book/Report/Conference proceedingConference contribution

Abstract

Optical metabolic imaging (OMI) quantifies the fluorescence intensities and lifetimes of NADH and FAD using two-photon microscopy. OMI allows for cells to be monitored within tumors, to design effective cancer therapies and personalize cancer treatment.

Original languageEnglish (US)
Title of host publicationCancer Imaging and Therapy, CANCER 2016
PublisherOSA - The Optical Society
ISBN (Print)9781943580101
DOIs
StatePublished - Jul 21 2014
EventCancer Imaging and Therapy, CANCER 2016 - Fort Lauderdale, United States
Duration: Apr 25 2016Apr 28 2016

Other

OtherCancer Imaging and Therapy, CANCER 2016
CountryUnited States
CityFort Lauderdale
Period4/25/164/28/16

ASJC Scopus subject areas

  • Electronic, Optical and Magnetic Materials
  • Mechanics of Materials

Fingerprint Dive into the research topics of 'Imaging cellular metabolic heterogeneity in cancer'. Together they form a unique fingerprint.

  • Cite this

    Skala, M. C., Walsh, A. J., Shah, A. T., Sharick, J. T., Heaster, T. M., Cook, R. S., Arteaga, C. L., Sanders, M. E., & Meszoely, I. (2014). Imaging cellular metabolic heterogeneity in cancer. In Cancer Imaging and Therapy, CANCER 2016 OSA - The Optical Society. https://doi.org/10.1364/CANCER.2016.JW4A.1